Regenerative 1B-EXO Compound K Mask
Commercial- Indications
- Skin aging, Skin firmness, Skin hydration
Company intelligence / Profile preview
VENN Skincare is a science-driven cosmeceutical company that applies advanced biotechnology to high-performance skincare. Founded in 2017 by Brian Oh and Kevin Mun, the company focuses on streamlining complex skincare routines through multi-functional 'all-in-one' formulations. VENN’s core innovation lies in its proprietary delivery systems, including Concentric Technology, which enables the effective penetration of active ingredients into the skin. A key scientific achievement of the firm is the successful solubilization of Ginsenoside Compound K, a potent antioxidant derived from Panax ginseng that was previously difficult to stabilize in topical applications. The company’s product portfolio is designed to address skin aging, hydration, and barrier repair using a combination of peptides, antioxidants, and fermentation-derived ingredients. VENN operates at the intersection of luxury beauty and clinical science, maintaining a global presence in high-end retail and professional dermatology channels.
19 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VENN Skincare.